Impingement syndrome refers to the compression of tissues between the bones and muscles or tendons in the shoulders. It is a common cause of shoulder pain and occurs when the rotator cuff or long head of the biceps tendon is pinched as it passes under the acromion. The key symptoms include pain in the front or side of the shoulder that is worse with overhead activities or lying on the affected side. Non-surgical treatments like corticosteroid injections, physical therapy, and medications are generally prescribed to reduce inflammation and strengthen muscles. The global impingement syndrome market is estimated to be valued at US$ 2,173.5 Mn in 2024 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The high success rate of non-surgical treatments in managing impingement syndrome symptoms represents a major market opportunity. Studies show that non-surgical treatments are able to provide relief in about 80-90% of impingement syndrome cases, preventing the need for invasive procedures like surgery. The non-invasive nature and relatively low costs associated with alternatives like corticosteroid injections and physical therapy are increasing their popularity over surgeries. Manufacturers focused on developing new drug formulations and therapies for non-surgical impingement syndrome treatment can gain a competitive advantage in the market. Educating patients and physicians about non-surgical options can further fuel the adoption of these alternatives.
Porter's Analysis
Threat of new entrants: The threat of new entrants is moderate as the market requires significant investment in R&D and regulatory approvals. However, new technologies can disrupt the market.
Bargaining power of buyers: The bargaining power of buyers is high due to the presence of many suppliers and generic products. Buyers can negotiate for better prices and demand high-quality products.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as there are substitute products available. Suppliers rely on a few players for raw materials.
Threat of new substitutes: The threat of substitutes is moderate as there are alternative treatment options available.
Competitive rivalry: The competitive rivalry is high due to many established international brands providing low-cost generic products.
SWOT Analysis
Strengths: Growing geriatric population suffering from lifestyle diseases, rising healthcare expenditure, and availability of advanced diagnostic techniques.
Weaknesses: High cost of branded therapies, patent expirations of blockbuster drugs, and stringent regulatory environment.
Opportunities: Untapped emerging markets, increasing research funding, and growth of healthcare infrastructure in developing nations.
Threats: Risk of drug failure during clinical trials, threat from alternative treatment options, and reimbursement issues in some countries.
Key Takeaways
The global Impingement Syndrome market is expected to witness high growth driven by the rising prevalence of shoulder injuries. The market size for 2024 is estimated at US$ 2,173.5 Mn and is anticipated to reach US$ 3,816.7 Mn by 2030 at a CAGR of 7.8% during the forecast period.
Regional analysis: North America dominated the global market in 2024 owing to the increasing healthcare expenditure and presence of major market players in the US. Asia Pacific is expected to grow at the fastest rate during the forecast period due to the large patient pool, growing medical tourism, and improving healthcare infrastructure in countries such as China and India.
Key players: Key players operating in the impingement syndrome market are Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell Signaling Technology, Inc., and Geno Technology Inc.
Impingement Syndrome Market By Types (Structural Impingement, Functional Impingement), By Diagnosis (Physical Examination, Imaging), By Treatment (Drug Treatment, Non-Pharmacological Treatment, Surgery), By End Users (Hospitals, Physical Therapists) - Global Forecast Till 2023 Global Impingement Syndrome Market Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making.
This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability.
It provides information on trends and developments, and focuses on Markets and materials, capacities and technologies, and on the changing structure of the Serotonin Supplements Market.Some of the key players operating for the global market analysis are ATOS Klinik Heidelberg GmbH & Co. KG (Germany), DePuy Synthes (US), Johnson & Johnson Services, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Abbott (US), Immediate Media Company Ltd. (US)Impingement Syndrome Market Research Coverage:Changing market dynamics of the industryTo get a comprehensive overview of the Impingement Syndrome Market.Historical, current and projected market size in terms of volume and valueIn-depth market segmentationCompetitive landscapeThe report presents an all-inclusive database in a systematic and highly comprehensive manner.
Our analysis team applies a tried and tested primary and secondary research methodology to provide accurate and indubitable findings.The global impingement syndrome market is segmented on the basis of types, diagnosis, treatment, and end users.
Imaging is further segmented into ultrasonography, arthrography and MRI.On the basis of treatment, the market is categorized into drug treatment, non-pharmacological treatment, and surgery.
Drug treatment is further segmented into corticosteroid, local anesthetic, NSAIDs, and other.
Fat pad syndrome also known as Hoffa's Syndrome is a problem with the Kneecap Alignment.
If there are problems with the kneecap alignment it can cause pinching or ‘Impingement’ on the fat pad.
For Treatment of Fat Pad Syndrome Call 8800299652.Visit: https://painfreephysiotherapy.com/fat-pad-syndrome/
Sachiya Steel International provides a quality collection of Cupro Nickel 90 Plates ,Sheets and Coils, where our offered collection is ensured to be in acquiescence by means of the international quality standards.
The main and wrought Cupro Nickel 90 / 10 Plates selected for sea water service comprise 10 percent of nickel.
An adding of iron in Cupro Nickel 90 / 10 Coils was made to upsurge its resistance to general corrosion, impingement corrosion and erosion resulting from the stormy movement of water comprising silt flowing and air bubbles at a superior velocity.Cupro Nickel 90 / 10 Slating Coils (UNS C70600) exhibit bigger corrosion resistance in seawater.
Meanwhile, Cupro Nickel 90 / 10 Perforated Coils are also being offered in different sizes and shapes to our customers.
When other elements are present, nickel in Cu-Ni 90 / 10 Sheets has the largest individual content after copper, compared with each other element.
Cu-Ni 90 / 10 Plates are a strong, ductile material exhibiting good corrosion resistance.Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 Plates | Cupro Nickel 90 PlatesCu-Ni 90 / 10 Coils are an alloy of copper, nickel and strengthening elements such as iron and manganese.
